MAPT and Alzheimer disease: In our study, we proposed a new perspective to explain the comorbidity of AD and depression that is Tau N368 fragment, elevated by CRS, directly binds PPAR-δ and represses its transactivation, leading to cognitive decline and depressive-like behaviors.